Greater Than One | GTO

Amanda Powers-Han Presenting at Xpectives Health Summit

Join Amanda Powers-Han, CMO of Greater Than One, at Xpectives Health Summit on April 18. Amanda will be taking the stage with Lori Johnston, Deputy Director, US Pulmonary Marketing at Grifols. She will be sharing why media plans should be dynamic not static.

Network Your Why Event

Bindhu Gopalan, our Chief Client Officer, will moderate the Network Your Why 2023 event on September 14 in NYC.  This event highlights the voices of diverse, purpose-driven professionals in the healthcare advertising industry, sharing their stories with BIPOC and LGBTQIA+ individuals looking to start careers in healthcare advertising.   For more information and to register […]

LinkedIn Live – Talking Tech: Generative AI

Tune in to our LinkedIn Live for a Talking Tech discussion on Generative AI in Healthcare and Marketing, this June 28th at 10:00am EST with Greater Than One’s CMO, Amanda Powers Han and our Chief Digital Officer, Brian Peterson.

Panel: What Makes Good DTC?

Join our Chief Client Officer, Bindhu Gopalan on April 20, 2023 at DTC National in Boston. Bindhu will be moderating a panel on What Makes Good DTC as part of the Medical Device track.

Talking DTC: Creating Compelling DTC Ads

Marketing success depends on creative excellence. In fact great creative is the best way to save media expenditures as effectiveness increases. Unfortunately much DTC advertising still fails to stand out. Join our Chief Client Officer, Bindhu, on January 25, 2023 at 1:30 pm as she and other marketing executives talk with Xpectives Health about how […]

GTO Named MM+M Top 100 Agency

In acknowledging Greater Than One (GTO) as a premiere healthcare agency of 2021, Medical Marketing and Media (MM+M) recognized that our unique integration of data, content, media, and technology makes us truly greater than the sum of our parts.

OXLUMO® (lumasiran) Launch wins ELITE 2021 Award

Greater Than One (GTO) has been recognized by PM360 for its success in conceiving and launching a virtual campaign to support OXLUMO® (lumasiran), a first-in-class therapy developed by Alnylam.

Honeycomb Health Modernizes Rare Disease Management

Chief Executive Officer and Honeycomb Health (HH) co-founder Elizabeth Apelles discusses why the high-tech nonprofit will forever change the lives of rare disease patients everywhere, and shares the buzz about her co-founder’s road trip to raise $3M dollars.

#GTO2Vote

We are proud to support our team members who use their voices and show up to support causes that matter.